Search | WHO COVID-19 Research Database

1.

Recommendations for prevention and management of children with neuromuscular disorders during the epidemic period of corona virus disease (COVID-19).

The Subspecialty Group of Endocrinologic, Hereditary; Metabolic, Diseases; the Society of Pediatrics, Chinese Medical Association; The Subspecialty Group of Neurology, the Society of Pediatrics Chinese Medical Association; The Subspecialty Group of Rehabilitation, the Society of Pediatrics Chinese Medical Association; Editorial Board of Chinese Journal of Applied Clinical, Pediatrics.

Chinese Journal of Applied Clinical Pediatrics ; 35(2):125-129, 2020.

Article in Chinese | EMBASE | ID: covidwho-2283940

2.

The inpatients treatment strategy of diabetic children and adolescents combined with coronavirus disease.

the Society of Pediatrics, Chinese Medical Doctor Association; The Subspecialty Group of Endocrinologic, Hereditary; Metabolic, Diseases; the Society of Pediatrics, Chinese Medical Association.

Chinese Journal of Applied Clinical Pediatrics ; 35(2):133-138, 2020.

Article in Chinese | EMBASE | ID: covidwho-2283939

3.

Assessment of the impact of psychobiotics supplementation on the occurrence of depression and anxiety disorders in people with a history of Covid-19 disease

Department of Pediatric Gastroenterology and Metabolic Diseases; Poznan University of Medical Sciences.

German Clinical Trials Register; 25/10/2021; TrialID: DRKS00026955

Clinical Trial Register | ICTRP | ID: ictrp-DRKS00026955

ABSTRACT

Condition:

COVID19
F41.2;Mixed anxiety and depressive disorder;F41.2

Intervention:

Group 1: Psychobiotic (Lactobacillus helveticus Rosell-52 i Bifidobacterium longum Rosell-175 in dose 3x10 9 CFU) for 6 weeks, 1 capsule per day
Group 2: Placebo for 6 weeks, 1 capsule per day

Primary outcome:

feeling anxiety and depression (HSCL-90, Hopkins Symptom Checklist)

Criteria:

Inclusion criteria: - Patient-reported postovid depression or anxiety changes (score = 12 on the HADS-anxiety subscale (HADS-A) and / or on the HADS-depression subscale (HADS-D),
- consent to participate in the study

Exclusion criteria: - pregnancy,
- severe coexisting diseases (liver cirrhosis, portal hypertension, renal failure, neoplastic diseases, diabetes, connective tissue diseases) and menopause,
- previously (pre-covid) diagnosed mental illnesses, psychiatric treatment,
- taking psychotropic drugs, stimulating / activating dietary supplements (ginger, guarana, ginseng, melatonin), drugs

4.

The inpatients treatment strategy of diabetic children and adolescents combined with coronavirus disease

The Subspecialty Group of Endocrinologic, Hereditary, Metabolic, Diseases, the Society of Pediatrics, Chinese Medical Doctor Association, The Subspecialty Group of Endocrinologic, Hereditary, Metabolic, Diseases, the Society of Pediatrics, Chinese Medical Association.

Chinese Journal of Applied Clinical Pediatrics ; 35(2):133-138, 2020.

Article in Chinese | Scopus | ID: grc-740777

5.

Recommendations for prevention and management of children with neuromuscular disorders during the epidemic period of corona virus disease (COVID-19)

The Subspecialty Group of Endocrinologic, Hereditary, Metabolic, Diseases, the Society of Pediatrics, Chinese Medical Association, The Subspecialty Group of Neurology, the Society of Pediatrics Chinese Medical Association, The Subspecialty Group of Rehabilitation, the Society of Pediatrics Chinese Medical Association, Editorial Board of Chinese Journal of Applied Clinical, Pediatrics.

Chinese Journal of Applied Clinical Pediatrics ; 35(2):125-129, 2020.

Article in Chinese | Scopus | ID: grc-740776